Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Children's Hospital of Michigan, Central Michigan University College of Medicine, 3950 Beaubien Boulevard, Detroit, MI 48201, USA.
Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Children's Hospital of Michigan, Central Michigan University College of Medicine, 3950 Beaubien Boulevard, Detroit, MI 48201, USA.
Immunol Allergy Clin North Am. 2022 Feb;42(1):65-76. doi: 10.1016/j.iac.2021.09.005.
The key to managing anaphylaxis is early epinephrine administration. This can improve outcomes and prevent progression to severe and fatal anaphylaxis. Delayed or lack of administration of epinephrine is associated with fatal reactions. Positioning in a recumbent supine position, airway management, and intravenous fluids are essential in its management. Antihistamines and glucocorticosteroids should not be prescribed in place of epinephrine. β-adrenergic agonists by inhalation are indicated for bronchospasm associated with anaphylaxis despite optimal epinephrine treatment. Long-term management of anaphylaxis includes the identification and avoidance of triggers; identification of cofactors, such as mast cell disorders; patient, parent, and caregiver education, and interventions to reduce allergen sensitivity, such as the use of venom immunotherapy for Hymenoptera hypersensitivity. Long-term management is covered in other articles. Consultation with an allergist/immunologist is recommended when necessary.
管理过敏反应的关键是早期给予肾上腺素。这可以改善结果并防止过敏反应发展为严重和致命的过敏反应。肾上腺素延迟或缺乏给予与致命反应有关。在管理中,采用仰卧位、气道管理和静脉补液至关重要。抗组胺药和糖皮质激素不应替代肾上腺素使用。尽管给予最佳肾上腺素治疗,吸入β-肾上腺素能激动剂仍适用于与过敏反应相关的支气管痉挛。过敏反应的长期管理包括识别和避免触发因素;确定伴发因素,如肥大细胞疾病;对患者、家长和照顾者进行教育,并采取干预措施降低过敏原敏感性,例如使用蜂类过敏的毒液免疫疗法。长期管理在其他文章中有介绍。必要时应咨询过敏症专家/免疫学家。